Open/Close
Español

Takeda Ireland Ltd.

Manufacturing, Pharmaceuticals
Takeda Ireland Ltd. ha sido certificada como Top Employers Ireland y Top Employers Europe y Top Employers Global.
  • Top Employers Ireland
  • Top Employers Europe
  • Top Employers Global

También certificada en

20 otros países

What Top Employers say about themselves

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

Takeda Ireland Ltd - Bray (DP)

Established in 1997 Takeda Ireland – Bray, is a Solid Oral Dosage Facility, which produces, packs and ships key strategic granulates, solid oral dosage tablets and final packaged blockbuster drug products to the worldwide markets including the major US, European, Japanese and valuable emerging markets. Bray produces products for the therapeutic areas of Cardiovascular, Metabolic, Central Nervous System (CNS) and Gastro-Intestinal.

Bray, currently has over 300 employees and is a shift operation, presently working twenty-four hours a day, seven days a week. To enable this, Takeda Ireland – Bray draws on the expertise of its world-class people, equipment and systems to meet the challenges of competing in our leading-edge markets. Starting in 2019 Bray is adding to its product portfolio and expanding facilities in order to produce two new oncology drugs, with commercial production scheduled for 2021.

Takeda Ireland Ltd - Grange Castle (API, DP and Biologics)

Constructed in 2002, the site now consists of 3 plants and employs over 200 people, with plans to continue expanding into 2021. The site represents a key strategic addition to the group's global production network.

Grange Castle started out developing and producing API's from clinical trial stages through to launch and full commercialisation. In 2017/2018 the site expanded it’s API operation to include a dedicated plant for the production of API, Drug Product and Packaging to support the production of a high tech oncology product for the treatment of multiple myeloma. In 2019, the Company also established a new standalone modular cell therapy facility dedicated to manufacturing a novel stem cell therapy, locally administered for the potential treatment of certain patients with perianal fistulae associated with Crohn’s disease.

Número de empleados: 500
Activo y los Países: 70

El análisis

Nuestro objetivo y completo análisis demuestra que Takeda Ireland Ltd. proporciona condiciones laborales excepcionales, apoya y fomenta el talento en todos los niveles de la empresa y se posiciona como líder en el mundo de los Recursos Humanos, esforzándose por mejorar las prácticas hacia sus empleados y evolucionar constantemente.

Nuestro programa de certificación permitirá a tu organización adaptarse con agilidad en el cambiante entorno de los recursos humanos.

How we certify